glp-1 efficacy Systematic review of the and safety of receptor agonists in the treatment of patients with type 2 diabetes mellitus GLP-1s and the Unintended Consequences

placebo in mild Alzheimer's) What this trial does not yet establish: Whether GLP-1 drugs prevent dementia that is the question the trial is designed to answer

Because CYP enzymes are not in the picture, the typical supplement-drug interaction routes (CYP3A4 induction, P-glycoprotein competition) simply do not apply to dulaglutide

Curr Protoc Mouse Biol , 2020, 10(1): e68

The sustained accumulation of ROS and the ROS-induced buildup of lipid peroxides further compromises the integrity of the plasma membrane, and ultimately, the cell will die due to ferroptosis

Evolving Concepts in Insulin Resistance

The authors of another very interesting study concluded that new approaches, going beyond those used so far, should be explored to help reduce the excessive burden caused to healthcare systems by lifestyle diseases